Combination diabetes pills for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests two diabetes medications—empagliflozin and glimepiride—used together to see if the combination works better and is safe for people with type 2 diabetes. If you're already on diabetes pills, this could help improve your blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years old or older.
- You must have been diagnosed with type 2 diabetes.
- You must have been taking diabetes pills (oral medications) for at least 8 weeks.
- You cannot have type 1 diabetes or diabetes caused by another condition.
- You cannot have severe diabetes-related eye complications.
- You cannot have used insulin for more than 7 days in the past 12 weeks, or steroids in the past 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding empagliflozin (a diabetes pill) to your current medicines (alogliptin and metformin) helps manage blood sugar better. It may be an option if your blood sugar is not well controlled with your current treatment.
This trial tests a combination of three common diabetes medications (metformin, an SGLT2 inhibitor, and a TZD) to see how well they work together and if they are safe. It may help people with type 2 diabetes who need better blood sugar control.
This trial tests a combination of three diabetes medicines (dapagliflozin, linagliptin, and metformin) in healthy adults to see how safe they are and how the body processes them. Participating could help make sure these medicines are safe for people with diabetes.
This study is testing two different diabetes pills—dapagliflozin or pioglitazone—in people with type 2 diabetes. The goal is to see which one works better when added to your current metformin and DPP-4 inhibitor. You may qualify if your blood sugar is not well controlled with your current medications.
This trial is testing different combinations of diabetes medicines to see which one helps keep your blood sugar more steady throughout the day. It's for people with type 2 diabetes who are already taking metformin and an SGLT-2 inhibitor but still have high blood sugar.
This study tests if a new medicine (elecoglipron) combined with dapagliflozin is safe and works better for adults with type 2 diabetes that isn't well controlled by diet or other medications.
Hear when a new Diabete Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.